UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000050649
Receipt number R000057707
Scientific Title Survey on Current Status and Treatment of Hepatitis and Liver Cancer in the Asia-Pacific Region
Date of disclosure of the study information 2023/03/23
Last modified on 2023/03/22 18:09:18

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Survey on Current Status and Treatment of Hepatitis and Liver Cancer in the Asia-Pacific Region

Acronym

A-HOC(APASL Hepatology/Oncology Consortium)

Scientific Title

Survey on Current Status and Treatment of Hepatitis and Liver Cancer in the Asia-Pacific Region

Scientific Title:Acronym

A-HOC(APASL Hepatology/Oncology Consortium)

Region

Japan Asia(except Japan)


Condition

Condition

Patients diagnosed with HCC at the collaborating institution beginning January 1, 2013, including newly diagnosed patients during the study enrollment period.

Classification by specialty

Hepato-biliary-pancreatic medicine Hepato-biliary-pancreatic surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The Asia-Pacific region is known for its high incidence of hepatitis and liver cancer (HCC) worldwide. This study will examine the actual incidence and treatment of HCC in the countries of the region, as well as the background of viral and non-viral hepatitis, and examine in depth the health and medical issues in each country.

Basic objectives2

Others

Basic objectives -Others

To understand the actual treatment status of HCC in Asia-Pacific countries and to deeply examine the actual status of the development of new treatment methods.

Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Overall survival from the time of diagnosis of HCC.

Key secondary outcomes

Diagnostic methods used as the basis for the diagnosis of HCC
Evaluation of liver function at the time of detection and the degree of progression of HCC
Causes of background liver damage
Sequence and combination of treatments
Status and efficacy of new drugs


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

1 years-old <=

Age-upper limit

120 years-old >

Gender

Male and Female

Key inclusion criteria

Patients diagnosed with HCC at the collaborating institution beginning January 1, 2013, including newly diagnosed patients during the study enrollment period.

Key exclusion criteria

None

Target sample size

10000


Research contact person

Name of lead principal investigator

1st name Hitoshi
Middle name
Last name Mochizuki

Organization

Yamanashi Prefectural Central Hospital

Division name

Genome Analysis Center / Department of Gastroenterology

Zip code

4008506

Address

1-1-1 Fujimi-cho, Kofu-city, Yamanashi-prefecture,Japan

TEL

+81-553-7111

Email

mochiduki-ypch@umin.ac.jp


Public contact

Name of contact person

1st name Izumi
Middle name
Last name Nakano

Organization

Asian Pacific Association for the Study of the Liver (APASL)

Division name

Secretariat

Zip code

160-0022

Address

1-24-7-920 Shinjyuku,Shinjyuku-ku, Tokyo, Japan

TEL

03-5312-7686

Homepage URL


Email

apasl_secretariat@apasl.info


Sponsor or person

Institute

Yamanashi Prefectural Centeral Hospital

Institute

Department

Personal name



Funding Source

Organization

Asian Pacific Association for the Study of the Liver (APASL)

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Yamanashi Prefectural Central Hospital Clinical Research Committee

Address

1-1-1 Fujimi,Kofu-city,Yamanashi-prefecture,Japan

Tel

+81-553-7111

Email

clinical-research@ych.pref.yamanashi.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 03 Month 23 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2023 Year 03 Month 14 Day

Date of IRB

2023 Year 03 Month 14 Day

Anticipated trial start date

2023 Year 04 Month 01 Day

Last follow-up date

2027 Year 12 Month 31 Day

Date of closure to data entry

2027 Year 12 Month 31 Day

Date trial data considered complete

2027 Year 12 Month 31 Day

Date analysis concluded

2028 Year 12 Month 31 Day


Other

Other related information

Observational studies tracking the background, epidemiology, diagnosis, treatment, and prognosis of HCC


Management information

Registered date

2023 Year 03 Month 22 Day

Last modified on

2023 Year 03 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000057707


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name